MétaCan
Menu
Back to cohort
Record W2014047240 · doi:10.4161/hv.6.9.11561

Recent advances in the development of novel mucosal adjuvants and antigen delivery systems

2010· article· en· W2014047240 on OpenAlex

Why this work is in the frame

A frame that forgets how it found something cannot be audited. These are the routes that admitted this work.

affAt least one author lists a Canadian institution in the pinned OpenAlex snapshot.

Bibliographic record

VenueHuman Vaccines · 2010
Typearticle
Languageen
FieldBiochemistry, Genetics and Molecular Biology
TopicRNA Interference and Gene Delivery
Canadian institutionsNational Research Council CanadaInstitute for Biological SciencesBrock University
Fundersnot available
KeywordsAdjuvantMedicineMucosal immunityImmunizationImmunologyMucosal immunologyVaccinationVaccine adjuvantImmune systemAntigenImmunity

Abstract

fetched live from OpenAlex

disposal, 6,7 as well as higher capacity for mass immunizations such as during influenza pandemics. 8espite the obvious advantages of mucosal vaccines, few have made it to market, and fewer currently remain approved for use in humans. 6,7,9A major obstacle in the development of an effective mucosal vaccine is the requirement to breach the mucosal epithelial barrier, present the antigen efficiently to the mucosal immune system, and overcome natural tolerance at mucosal surfaces. 3,10djuvants can be classified into one of two broad categories: they are either immunostimulatory molecules like CpG oligonucleotide (ODN), bacterial toxins and cytokines or delivery vehicles like liposomes, microparticles and emulsions.In many instances, however, adjuvants may posses dual (both immunostimulation and antigen delivery) or overlapping functions.All currently approved mucosal vaccines are based on live-attenuated or killed pathogen cells 3,6 which, although highly effective, raise concerns regarding potential reversion to virulence and reactogenicity.Therefore, there is ongoing extensive research into the development of novel mucosal adjuvants and non-replicating delivery systems (Table 1), especially for antigens which are not highly immunogenic on their own. 1,3,6,[11][12]2][13][14] Most of these mucosal adjuvants and delivery systems have been extensively reviewed recently. [15][16]6][17][18][19][20] This review focuses on the recent approaches involving archaeal lipid mucosal vaccine adjuvant and delivery (AMVAD) system, 3',5'-cyclic diguanylic acid (c-di-GMP) and detoxified bacterial AB 5 toxins.M cell targeted mucosal vaccine delivery strategies are also discussed. Lipid-Based and Archaeal Lipid Mucosal Vaccine Adjuvant and DeliverySeveral lipid-based or lipid-containing mucosal adjuvants are currently being evaluated for mucosal vaccination (Table 1). 15,18,[20][21]1][22][23][24] For some of these adjuvants, issues of actual or perceived toxicity, stability, complexity and scalability of preparation as well as efficacy and duration of induced immune responses remain unresolved. 6,11,13,25,26For instance, ISCOMATRIX TM (colloidal, spherical structures, comprising of saponin such as Quil A, cholesterol and a phospholipid) has potential as a mucosal adjuvant 27,28 but it may not be easily amenable for use with hydrophilic protein antigens, and concerns/perceptions regarding saponin toxicity remain. 29,30Cochleate vaccines derived by interaction of multivalent cations with ester lipid liposomes 31,32 or with proteoliposomes 24,33 have been investigated for mucosal

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Bench or experimental · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.644
Threshold uncertainty score0.258

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.021
GPT teacher head0.282
Teacher spread0.261 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it